|
|
Volumn 92, Issue 1, 2003, Pages 141-142
|
|
Uroselectivity: End of the road?
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALFUZOSIN;
ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT;
ALPHA 1A ADRENERGIC RECEPTOR;
ALPHA 1A ADRENERGIC RECEPTOR BLOCKING AGENT;
ALPHA 1D ADRENERGIC RECEPTOR;
ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT;
DARIFENACIN;
DOXAZOSIN;
FIDUXOSIN;
MUSCARINIC M1 RECEPTOR;
MUSCARINIC M2 RECEPTOR;
MUSCARINIC M3 RECEPTOR;
MUSCARINIC M3 RECEPTOR ANTAGONIST;
MUSCARINIC RECEPTOR BLOCKING AGENT;
OXYBUTYNIN;
PARVOSIN;
PRAZOSIN;
RS 700 004;
SOLIFENACIN;
TAMSULOSIN;
TERAZOSIN;
TOLTERODINE;
UK 338 003;
UNCLASSIFIED DRUG;
ASTHENIA;
CARDIOVASCULAR SYMPTOM;
CLINICAL TRIAL;
CONSTIPATION;
DISEASE COURSE;
DRUG ABSORPTION;
DRUG EFFICACY;
DRUG SELECTIVITY;
DRUG TARGETING;
DRUG TOLERABILITY;
FATIGUE;
HUMAN;
HYPOTENSION;
OVERACTIVE BLADDER;
PATIENT COMPLIANCE;
PRIORITY JOURNAL;
PROSTATE HYPERTROPHY;
PROTEIN TARGETING;
QUALITY OF LIFE;
SHORT SURVEY;
SLOW RELEASE FORMULATION;
URGE INCONTINENCE;
URINE FLOW RATE;
URODYNAMICS;
VERTIGO;
XEROSTOMIA;
ADRENERGIC ALPHA-ANTAGONISTS;
ANTIMUTAGENIC AGENTS;
DRUG DESIGN;
DRUG INDUSTRY;
HUMANS;
MALE;
PROSTATIC HYPERPLASIA;
URINARY INCONTINENCE;
|
|
EID: 0037825838
PISSN: 14644096
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1464-410X.2003.04292.x Document Type: Short Survey |
|
Times cited : (3)
|
|
References (0)
|
